Condrotide ™ is a class III CE marked medical device containing 20 mg/ml polynucleotides (PN).
Polynucleotides are physiological components naturally occurring in the human body, and their safety has been proven in in vivo and in vitro tests required by ISO-10993 and during many years of clinical use in other therapies (e.g. wound healing).Condrotide ™ not only reduces the symptoms of pain, but also stimulates the healing and regeneration processes of articular cartilage
- Significantly reduces pain symptoms
- Reduces the consumption of NSAIDs
- Increases the range of motion of the joint and improves its functionality
- Accelerates the return to sports and recreation
- Regenerates articular cartilage
The HemiCAP® implants intraoperatively recreate the patients' articular cartilage surface convexities. This unique mapping technology enables the surgeon to place the implant so the implant becomes part of the patient's natural curvatures - both in the medial to lateral aspect as well as the anterior to posterior plane.
RegJoint™ is indicated for arthroplasties in small joints in hand and foot for patients suffering of rheumatoid arthritis or osteoarthritis. The specific target joints are metatarsal I-V, V (MTI I-V) in foot, carpometacarpal (CMC I) and metacarpophalangeal II-V (MCP II-V) joints in hand.
MED&CARE Sp. z o.o.
ul. Mławska 13
81-204 Gdynia, Poland
phone: +48 58 776 22 75
fax: +48 58 350 97 57
mobile: +48 506 399 272
Number: PL 92 1020 1853 0000 9502 0124 1017
Bank PKO BP SA, I Oddział w Gdyni
Kod BIC (Swift): BPKOPLPW